Quick Takeaways
- Raymond Prudo-Chlebosz filed SCHEDULE 13D/A for Akari Therapeutics, Plc Ordinary Shares, $0.0001 par value (AKTX).
- Disclosed ownership: 9.3%.
- Date of event: 14 Nov 2024.
Raymond Prudo-Chlebosz - 14 Nov 2024 SCHEDULE 13D/A Report for Akari Therapeutics, Plc Ordinary Shares, $0.0001 par value (AKTX)
- Filing Manager
- Raymond Prudo-Chlebosz
- Reporting Manager
- Ray Prudo, M.D.
- Symbol
- AKTX
- Shares outstanding
- 52,974,202,151 shares
- Disclosed Ownership
- 4,926,600,800 shares
- Ownership
- 9.3%
- Form type
- SCHEDULE 13D/A
- Filing time
- 14 Feb 2025, 17:00:03 UTC
- Date of event
- 14 Nov 2024
- Next filing
- 04 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Raymond Prudo-Chlebosz disclosed 9.3% ownership in Akari Therapeutics, Plc Ordinary Shares, $0.0001 par value (AKTX) on 14 Nov 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 17:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Ray Prudo, M.D. | 9.3% | 4,926,600,800 | 4,087,124,600 | 839,476,200 | /s/ Ray Prudo | Reporting Person | 0001653262 |
| RPC Pharma Limited | 1.5% | 800,766,600 | 0 | 800,766,600 | /s/ Ray Prudo | Authorized Person | |
| Praxis Trustees Limited As trustee of The Sonic Healthcare Holding Company | 0.1% | 38,709,600 | 0 | 38,709,600 | /s/ Jodie Travers | Director for and on behalf of Praxis Trustees Limited |